ACM
XBI icon

Advisors Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Advisors Capital Management’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,112
Closed -$505K – 530
2024
Q3 		$505K Buy
5,112
+37
+0.7% +$3.63K 0.01% 367
2024
Q2 		$471K Sell
5,075
-121
-2% -$10.8K 0.01% 367
2024
Q1 		$493K Buy
5,196
+77
+2% +$7.14K 0.01% 361
2023
Q4 		$457K Buy
5,119
+556
+12% +$41.3K 0.01% 356
2023
Q3 		$333K Buy
4,563
+248
+6% +$19.8K 0.01% 345
2023
Q2 		$359K Sell
4,315
-493
-10% -$41.2K 0.01% 352
2023
Q1 		$366K Buy
4,808
+427
+10% +$35.4K 0.01% 337
2022
Q4 		$364K Buy
4,381
+549
+14% +$44.4K 0.01% 348
2022
Q3 		$322K Sell
3,832
-957
-20% -$80.7K 0.01% 385
2022
Q2 		$356K Buy
4,789
+1,712
+56% +$129K 0.01% 338
2022
Q1 		$277K Buy
3,077
+732
+31% +$67.6K 0.01% 379
2021
Q4 		$263K Buy
2,345
+395
+20% +$47.6K 0.01% 382
2021
Q3 		$245K Buy
1,950
+17
+0.9% +$2.19K 0.01% 378
2021
Q2 		$262K Sell
1,933
-140
-7% -$18.4K 0.01% 345
2021
Q1 		$281K Buy
2,073
+108
+5% +$16.2K 0.01% 323
2020
Q4 		$276K Sell
1,965
-203
-9% -$26K 0.01% 306
2020
Q3 		$242K Buy
2,168
+37
+2% +$4.15K 0.01% 281
2020
Q2 		$239K Buy
+2,131
New +$210K 0.01% 268

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Advisors Capital Management's XBI Position: Q4 2024 in Review

Advisors Capital Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2024, closing a stake of 5,112 shares — an estimated $505K sold.

Advisors Capital Management first reported a position in XBI in Q2 2020 and held it in 18 quarters. The position peaked at $505K in Q3 2024. 738 funds tracked by Wall St. Rank hold XBI as of Q4 2024.

  • Advisors Capital Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2024 after selling out during the quarter.
  • Advisors Capital Management sold 5,112 State Street SPDR S&P Biotech ETF shares in Q4 2024, an estimated $505K.
  • Advisors Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and held it in 18 quarters.
  • Advisors Capital Management's State Street SPDR S&P Biotech ETF position peaked at $505K in Q3 2024.
  • 738 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2024.

Based on Advisors Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.